A study published in JAMA Oncology recently showed that treatment with which of the following drug types was just as effective as BRAF- and MEK-targeted therapies for melanoma and also limited the risk of life-threatening adverse events?
A. programmed death protein 1 inhibitors
B. tyrosine kinase inhibitors
C. C-KIT targeted drugs
D. cytotoxic T lymphocyte-associated molecule-4 inhibitors
-----
To see the correct answer, click here.
